The COPDnet integrated care model

International Journal of COPD

Volumn 13, Issue , 2018, Pages 2225-2235

  Koolen, Eleonore H ^a   van der Wees, Philip J ^a   Westert, Gert P ^a   Dekhuijzen, Richard ^a   Heijdra, Yvonne F ^a   van ’t Hul, Alex J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic care model; COPD; Copd management; Health status; Integrated care

Indexed keywords

ARTICLE; BODY WEIGHT LOSS; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; COPDNET INTEGRATED CARE MODEL; COST EFFECTIVENESS ANALYSIS; DISEASE BURDEN; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRONIC HEALTH RECORD; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH STATUS; HUMAN; LUNG DIFFUSION; LUNG VOLUME; MATHEMATICAL MODEL; MOTIVATION; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PROVOCATION TEST; QUESTIONNAIRE; SECONDARY HEALTH CARE; SIX MINUTE WALK TEST; SPIROMETRY; TERTIARY HEALTH CARE; COST OF ILLNESS; DECISION SUPPORT SYSTEM; DISEASE EXACERBATION; DISEASE MANAGEMENT; INTEGRATED HEALTH CARE SYSTEM; METHODOLOGY; PALLIATIVE THERAPY; PRIMARY HEALTH CARE; PROCEDURES; QUALITY OF LIFE; SECONDARY CARE CENTER; THEORETICAL MODEL;

COST OF ILLNESS; DECISION SUPPORT TECHNIQUES; DELIVERY OF HEALTH CARE, INTEGRATED; DISEASE MANAGEMENT; DISEASE PROGRESSION; HUMANS; MODELS, THEORETICAL; PALLIATIVE CARE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RESEARCH DESIGN; SECONDARY CARE CENTERS;

EID: 85058450943     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S150820     Document Type: Article

References (65)

1. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
2. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97(suppl C):S3–S14.
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773.
4. Porter ME. What is value in health care? N Engl J Med. 2010;363(26): 2477–2481.
5. Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Engl J Med. 2016;374(6):504–506.
6. Worth H, Buhl R, Criee CP, Kardos P, Mailander C, Vogelmeier C. The ‘real-life’ COPD patient in Germany: the DACCORD study. Respir Med. 2016;111:64–71.
7. Buhl R, Criee CP, Kardos P, et al. A year in the life of German patients with COPD: the DACCORD observational study. Int J Chron Obstruct Pulmon Dis. 2016;11:1639–1646.
8. Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L. The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J. 2014;43(4):993–1002.
9. Ke X, Marvel J, Yu TC, et al. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1689–1703.
10. Fuchs S, Henschke C, Blumel M, Busse R. Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness. Dtsch Arztebl Int. 2014;111(26):453–463.
11. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670–691.
12. Peytremann-Bridevaux I, Burnand B. Disease management: a proposal for a new definition. Int J Integr Care. 2009;9:e16.
13. Nici L, ZuWallack R; American Thoracic Society Subcommittee on Integrated Care of the CP. An official American Thoracic Society workshop report: the Integrated Care of The COPD Patient. Proc Am Thorac Soc. 2012;9(1):9–18.
14. Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD009437.
15. Mendes de Oliveira JC, Studart Leitão Filho FS, Malosa Sampaio LM, et al. Outpatient vs. home-based pulmonary rehabilitation in COPD: a randomized controlled trial. Multidiscip Respir Med. 2010;5(6): 401–408.
16. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34(11):608–614.
17. Smith BJ, Appleton SL, Bennett PW, et al. The effect of a respiratory home nurse intervention in patients with chronic obstructive pulmonary disease (COPD). Aust N Z J Med. 1999;29(5):718–725.
18. Sridhar M, Taylor R, Dawson S, Roberts NJ, Partridge MR. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2008;63(3):194–200.
19. Strijbos JH, Postma DS, van Altena R, Gimeno F, Koeter GH. A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months. Chest. 1996;109(2): 366–372.
20. Achelrod D, Welte T, Schreyogg J, Stargardt T. Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)-A large population-based cohort study. Health Policy. 2016;120(9):1029–1039.
21. Kayyali R, Odeh B, Frerichs I, et al. COPD care delivery pathways in five European Union countries: mapping and health care professionals’ perceptions. Int J Chron Obstruct Pulmon Dis. 2016;11:2831–2838.
22. Long Alliantie Nederland (LAN) [Lung Alliance Netherlands]. Zorgstandaard COPD [Care Standard COPD]; 2016. Available from: http://www.longalliantie.nl/zorgstandaard-copd. Accessed March 16, 2018. Dutch.
23. Vanhaecht K, Van Gerven E, Deneckere S, et al. 7-fasenmodel voor de ontwikkeling, implementatie, evaluatie en continue opvolging van zorgpaden [The 7 phase model to develop, implement, evaluate and continuously follow up care pathways]. Tijdschr Geneeskd. 2011;10:8. Dutch.
24. Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manag Care Q. 1996;4(2):12–25.
25. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff. 2009;28(1):75–85.
26. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007;167(6): 551–561.
27. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20(6):64–78.
28. Agusti A, MacNee W. The COPD control panel: towards personalised medicine in COPD. Thorax. 2013;68(7):687–690.
29. van den Akker EF, Van’t Hul AJ, Birnie E, Chavannes NH, Rutten-van Molken MP, In’t Veen JC. Comprehensive diagnostic assessment of health status of patients with asthma or COPD: a Delphi Panel Study among Dutch Experts. COPD. 2017;14(2):190–199.
30. Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109.
31. van den Akker EF, van’t Hul AJ, Chavannes NH, et al. Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study. Int J Chron Obstruct Pulmon Dis. 2015;10:2413–2422.
32. Effing TW, Bourbeau J, Vercoulen J, et al. Self-management programmes for COPD: moving forward. Chron Respir Dis. 2012;9(1):27–35.
33. Effing TW, Vercoulen JH, Bourbeau J, et al. Definition of a COPD self-management intervention: International Expert Group consensus. Eur Respir J. 2016;48(1):46–54.
34. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6 pt 1):1918–1930.
35. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 pt 1): 1005–1026.
36. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif. 1992;28:183–218.
37. Elwyn G, Dehlendorf C, Epstein RM, Marrin K, White J, Frosch DL. Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems. Ann Fam Med. 2014;12(3):270–275.
38. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
39. Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367.
40. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/ European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.
41. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995; 273(1):59–65.
42. van Ranst D, Otten H, Meijer JW, van’t Hul AJ. Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis. 2011;6:647–657.
43. Peters JB, Daudey L, Heijdra YF, Molema J, Dekhuijzen PN, Vercoulen JH. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res. 2009;18(7): 901–912.
44. Vercoulen JH. A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour. Chron Respir Dis. 2012;9(4):259–268.
45. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
46. Kruis AL, Soljak M, Chavannes NH, Elkin SL. COPD multidisciplinary team meetings in the United Kingdom: health care professionals’ perceptions of aims and structure. COPD. 2016;13(5):639–641.
47. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6):CD000259.
48. Reticker AL, Nici L, ZuWallack R. Pulmonary rehabilitation and palliative care in COPD: two sides of the same coin? Chron Respir Dis. 2012;9(2):107–116.
49. Trappenburg JC, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax. 2011;66(11):977–984.
50. Kruis AL, Smidt N, Assendelft WJ, et al. Cochrane corner: is integrated disease management for patients with COPD effective? Thorax. 2014;69(11):1053–1055.
51. Kardos P, Vogelmeier C, Buhl R, Criee CP, Worth H. The prospective non-interventional DACCORD study in the National COPD Registry in Germany: design and methods. BMC Pulm Med. 2015;15:2.
52. Bourbeau J, Tan WC, Benedetti A, et al. Canadian Cohort Obstructive Lung Disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD. 2014;11(2):125–132.
53. Tottenborg SS, Thomsen RW, Nielsen H, Johnsen SP, Frausing Hansen E, Lange P. Improving quality of care among COPD outpatients in Denmark 2008–2011. Clin Respir J. 2013;7(4):319–327.
54. Panella M, Marchisio S, Brambilla R, Vanhaecht K, Di Stanislao F. A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study. BMC Med. 2012;10:71.
55. Panella M, Marchisio S, Demarchi ML, Manzoli L, Di Stanislao F. Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial. Qual Saf Health Care. 2009;18(5):369–373.
56. Vanhaecht K, Sermeus W, Peers J, et al. The impact of care pathways for patients with proximal femur fracture: rationale and design of a cluster-randomized controlled trial. BMC Health Serv Res. 2012;12: 124.
57. Vanhaecht K, Sermeus W, Peers J, et al. The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial. Trials. 2010; 11:111.
58. Grol R, Grol R. Improving Patient Care: The Implementation of Change in Health Care. 2nd ed. Chichester, UK; Hoboken, NJ, USA: Wiley Blackwell, BMJ/Books; 2013.
59. Jonkman NH, Schuurmans MJ, Jaarsma T, Shortridge-Baggett LM, Hoes AW, Trappenburg JC. Self-management interventions: proposal and validation of a new operational definition. J Clin Epidemiol. 2016; 80:34–42.
60. Kaptein AA, Fischer MJ, Scharloo M. Self-management in patients with COPD: theoretical context, content, outcomes, and integration into clinical care. Int J Chron Obstruct Pulmon Dis. 2014;9:907–917.
61. Young HM, Apps LD, Harrison SL, Johnson-Warrington VL, Hudson N, Singh SJ. Important, misunderstood, and challenging: a qualitative study of nurses’ and allied health professionals’ perceptions of implementing self-management for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1043–1052.
62. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391): 1225–1230.
63. Sampson R, Barbour R, Wilson P. Email communication at the medical primary-secondary care interface: a qualitative exploration. Br J Gen Pract. 2016;66(648):e467–e473.
64. Sampson R, Barbour R, Wilson P. The relationship between GPs and hospital consultants and the implications for patient care: a qualitative study. BMC Fam Pract. 2016;17:45.
65. Sheu L, Fung K, Mourad M, Ranji S, Wu E. We need to talk: primary care provider communication at discharge in the era of a shared electronic medical record. J Hosp Med. 2015;10(5):307–310.